Kefah Mokbel: What Makes DCIS Develop and What Makes It Progress to Invasive Breast Cancer?
Kefah Mokbel/ LinkedIn

Kefah Mokbel: What Makes DCIS Develop and What Makes It Progress to Invasive Breast Cancer?

Kefah Mokbel, Professor of Medicine (Honorary) at Cardiff University School of Medicine, shared on LinkedIn:

“What makes DCIS more likely to develop—and what makes it progress to invasive breast cancer? These are different questions, and this study shows why that distinction matters.

A systematic review and meta-analysis by Weiner and colleagues in Breast Cancer Research examined breast density, body mass index (BMI), and other metabolic and breast tissue factors across 35 observational studies.

DCIS—ductal carcinoma in situ—involves abnormal cells confined within the breast ducts. Some lesions become invasive; others do not.

Here are the key findings:

Breast density showed the clearest association with developing DCIS.

Higher mammographic density was associated with a pooled relative effect of 2.36 (95% confidence interval: 1.79–3.11)—approximately a 2.4-fold association compared with lower density. This describes a relative association, not an individual’s absolute probability. Evidence was more consistent before menopause; the postmenopausal estimate was substantially less precise.

The BMI findings differed by menopausal status.

Before menopause, higher BMI was associated with less frequent DCIS development (pooled relative effect 0.74; 95% CI 0.63–0.87). After menopause, the association pointed towards increased risk, but the primary result was not statistically conclusive (1.17; 95% CI 0.99–1.37).

Crucially, the certainty of the BMI evidence was rated very low. These findings do not establish that higher body weight protects against DCIS or that changing weight would produce these effects.

The biggest unanswered question concerns progression.

No eligible study examined whether these factors predicted progression from untreated DCIS to invasive cancer. Evidence on recurrence after treatment was limited and too heterogeneous for pooled analysis. Evidence on other metabolic and local tissue measures was also sparse.

Why does this matter?

Factors associated with developing DCIS cannot automatically tell us how an existing lesion will behave—or which patients can safely avoid treatment.

The review strengthens the rationale for studying breast density and metabolic biology, while showing how much evidence is still needed to guide personalised DCIS management. Its observational findings identify associations, not causes or a validated treatment decision tool.”

Title: Breast density and metabolic factors in DCIS: systematic review and meta-analysis

Authors: Julian J. Weiner, Lisa A. van den Heuvel, Stevie van der Mierden, DIRECT-DCIS Consortium, Esther H. Lips, Jelle Wesseling

Read the Full Article on Breast Cancer Research

Kefah Mokbel: What Makes DCIS Develop and What Makes It Progress to Invasive Breast Cancer?

You can also read: Lumpectomy Margin Width and Local Recurrence in DCIS: Findings From NSABP B-35

Kefah Mokbel: What Makes DCIS Develop and What Makes It Progress to Invasive Breast Cancer?